


| Key | % Net Assets |
|---|---|
| 9.6% | |
| 5.3% | |
| 4.4% | |
| 4.3% | |
| 76.4% |
| Name | % Net Assets |
|---|---|
| Treausry 0% 9 July 2012 | 9.6% |
| Treasury Bill 3 Sep 2012 | 5.3% |
| AstraZeneca | 4.4% |
| Royal & Sun Alliance | 4.3% |
| Reed Elsevier | 4.1% |
| Treasury 0% 2012 | 3.7% |
| BP | 3.3% |
| Amlin 6.5% 2026 | 3.2% |
| ETFS Physical Gold | 3.1% |
| Treasury 0% 6 June 2012 | 2.7% |
No asset data available.
| Date | n/a |
|---|---|
| Bid | 0.00 |
| Offer | 0.00 |
| Currency | n/a |
| Change | 0.00 |
| % | n/a |
| YTD change | 0.00 |
| YTD % | n/a |
| Fund Inception | 17/05/2006 |
|---|---|
| Fund Manager | Robert Waugh |
| TER | 0.90 (31-Dec-2013) |
| Minimum Investment | |
|---|---|
| Initial | 1000 |
| Additional | n/a |
| Savings | n/a |
| Charges | |
|---|---|
| Initial | n/a |
| Annual Mang't | 0.75% |
| Exit | n/a |
| Name | % |
|---|---|
| No risk data available. | |
You are here: research